Plain-English translation of NCT05605704 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Diabetes Mellitus, Type 2 research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing whether , a treatment made from olive leaf extract, can help people with type 2 diabetes control their blood sugar better. You would take a 400 mg pill once daily for three months. Researchers will measure how well the medication works by checking your blood sugar levels before and during the study.
Type 2 diabetes affects millions of people, and while current treatments work for many, researchers are looking for additional options that might help control blood sugar naturally. This study explores whether the medication, derived from a natural source, could be a useful addition to diabetes management.
You likely qualify if…
You likely don't qualify if…
You would visit one of the study sites (either an emergency department or an endocrinology clinic in Tunisia) and receive baseline blood tests to check your blood sugar, cholesterol, and inflammation markers. You would then be randomly assigned to take either the medication or a placebo (a pill with no active ingredient) once daily for three months. During this time, you may wear a continuous glucose monitor to track your blood sugar patterns, and you will have follow-up blood tests to see how the treatment affected your levels.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
Tunisia
Phase
Large-scale testing
Sponsor
University of Monastir
Enrollment target
~500 participants
Started
January 2023
Primary completion
September 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 100 Years
Last updated on clinicaltrials.gov in June 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Nouira semir, Pr
University of Monastir
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.